Imagine trying to understand what is happening inside a newborn's body during a critical moment. Doctors are looking for better ways to monitor these tiny patients. A review of 43 studies suggests that small particles called extracellular vesicles (EVs) could play a major role in this process.
These EVs are found consistently in the fluids of both full-term and premature babies across many different conditions. Because they appear so regularly, researchers believe they might act as markers to help identify health issues or predict how a baby's condition might progress.
While these findings are promising, it is important to note that the evidence is still limited. The studies looked at were very different from one another in their methods. Because of this, we cannot yet say for sure exactly what these particles do or how they can be used in a hospital setting just yet.
Common questions
What are extracellular vesicles?
Extracellular vesicles, or EVs, are small particles found in the biological fluids of newborns. This review looked at 43 studies to see how these particles behave. They appear consistently across various conditions in both term and preterm babies, which suggests they might play a role in how the body functions.
Can these particles be used to diagnose health issues in babies?
There is potential for these particles to be used as biomarkers. A biomarker is a measurable sign of a condition. While they are consistently present in neonatal fluids, the evidence is currently limited and more standardized research is needed before they can be used reliably in clinical practice.
Is the evidence for using these particles in newborns certain?
The certainty of these findings is currently low. Because the 43 studies included in the review used very different methods and had small to moderate sample sizes, more research is needed to confirm exactly how these particles function in a clinical setting.
